Why it matters

This is strong negative-side evidence that medical-AI deployment is often constrained less by model capability than by weak generalizability, narrow disease coverage, and insufficient prospective testing.

Primary trail

Go to the source

Read the evidence behind this analysis. External links open in a new tab.

Nature